The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Serc 8mg Tablets

8 milligram(s) Tablet

Primecrown 2010 LimitedPPA1633/026/001

Main Information

Trade NameSerc 8mg Tablets
Active SubstancesBetahistine dihydrochloride
Strength8 milligram(s)
Dosage FormTablet
Licence HolderPrimecrown 2010 Limited
Licence NumberPPA1633/026/001

Group Information

ATC CodeN07CA Antivertigo preparations
N07CA01 betahistine

Status

Authorised/WithdrawnAuthorised
Licence Issued08/02/2013
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA 108/11/1
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListBetahistine 8mg Tablets
Interchangeable List CodeIC0084-009-002
Interchangeable List DocumentPDF of Interchangeable List
« Back